Superiority of fecal carcinoembryonic antigen as diagnosis marker for adenomatous polyposis coli and asymptomatic colorectal cancer.

Linfang LiWenshen GuXingping WuYufeng AoYiling SongXiaohui LiQiuyao Zeng

Published in: Therapeutic advances in gastroenterology (2021)

FCEA has been demonstrated to be a favorable diagnostic marker in intestinal diseases, especially in the APC, asymptomatic CRC, and 'double-negative' or 'triple-negative' CRC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
escherichia coli
peritoneal dialysis
patient reported outcomes
chronic rhinosinusitis